PTIX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Protagenic Therapeutics received FDA pre-IND feedback supporting a new IND for PT00114 in generalized anxiety disorderAug 20, 2026
- Protagenic Therapeutics announces completion of enrollment and dosing in Phase 1 MAD studyNov 13, 2025
- Protagenic Therapeutics advances PT00114 into multiple-dose Phase 1 trial, positioning for Phase 2 in stress and mood disordersAug 21, 2025
- Protagenic Therapeutics announces grant of new patent in Japan for modified stilbenoid program drug candidatesJul 30, 2025